scispace - formally typeset
D

David Pépin

Researcher at Harvard University

Publications -  61
Citations -  2683

David Pépin is an academic researcher from Harvard University. The author has contributed to research in topics: Anti-Müllerian hormone & Medicine. The author has an hindex of 17, co-authored 48 publications receiving 1952 citations. Previous affiliations of David Pépin include Massachusetts Eye and Ear Infirmary & Ottawa Hospital Research Institute.

Papers
More filters
Journal ArticleDOI

Homogenization of regional river dynamics by dams and global biodiversity implications.

TL;DR: Long-term streamflow records are used on intermediate-sized rivers across the continental United States to show that dams have homogenized the flow regimes on third- through seventh-order rivers in 16 historically distinctive hydrologic regions over the course of the 20th century.
Journal ArticleDOI

AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy

TL;DR: It is shown that long-term parenteral administration of superphysiological doses of MIS, using either an adeno-associated virus serotype 9 (AAV9) gene therapy vector or recombinant protein, resulted in a complete arrest of folliculogenesis in mice, representing a unique mechanism of contraception that spares the pool of quiescent primordial follicles (ovarian reserve).
Journal ArticleDOI

Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance

TL;DR: The results suggest that chemotherapeutics may be stimulative to cancer stem cells and that selective inhibition of these cells by treating with MIS or targeting LIN28 should be considered in the development of therapeutics.